Trial access to biomedical journals

Trial access to two biomedical journals is now available up until 3 April 2015:

Science Translational Medicine publishes research articles from the international, medical, scientific and engineering communities. Despite our understanding of the molecular basis of thousands of human diseases, we only have treatments for a few hundred. Science Translational Medicine seeks to close this knowledge gap and accelerate the development of new therapies.

Science Signaling publishes key findings in the multidisciplinary field of cellular signalling and regulatory biology in physiology and disease. Research results are relevant to understanding how cells adapt to changing environments and respond to stimuli within living organisms.